Fmr LLC Crinetics Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 14,125,999 shares of CRNX stock, worth $622 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

14,125,999

Previous 14,031,269 0.68%

Holding current value

$622 Million

Previous $471 Million 13.67%

% of portfolio

0.02%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$25.56 - $33.76 $2.42 Million - $3.2 Million	94,730 Added 0.68%	14,125,999 $406 Million
Q1 2025 May 12, 2025	BUY	$32.3 - $53.15 $165 Million - $271 Million	5,103,183 Added 57.16%	14,031,269 $471 Million
Q4 2024 Feb 13, 2025	BUY	$50.66 - $60.69 $227 Million - $271 Million	4,472,316 Added 100.37%	8,928,086 $456 Million
Q3 2024 Nov 13, 2024	BUY	$43.83 - $54.98 $15.7 Million - $19.7 Million	358,975 Added 8.76%	4,455,770 $228 Million
Q2 2024 Aug 13, 2024	SELL	$42.12 - $51.91 $15.5 Million - $19 Million	-366,881 Reduced 8.22%	4,096,795 $183 Million
Q1 2024 May 13, 2024	BUY	$34.76 - $46.81 $14.6 Million - $19.7 Million	419,811 Added 10.38%	4,463,676 $209 Million
Q4 2023 Feb 13, 2024	BUY	$25.62 - $37.07 $48.8 Million - $70.5 Million	1,903,004 Added 88.89%	4,043,865 $144 Million
Q3 2023 Nov 13, 2023	BUY	$15.97 - $30.59 $16.9 Million - $32.4 Million	1,057,947 Added 97.69%	2,140,861 $63.7 Million
Q2 2023 Aug 11, 2023	BUY	$15.73 - $23.6 $2.55 Million - $3.82 Million	161,956 Added 17.59%	1,082,914 $19.5 Million
Q1 2023 May 11, 2023	SELL	$15.31 - $21.1 $14.7 Million - $20.3 Million	-962,160 Reduced 51.09%	920,958 $14.8 Million
Q4 2022 Feb 13, 2023	SELL	$15.49 - $19.05 $12.4 Million - $15.2 Million	-798,485 Reduced 29.78%	1,883,118 $34.5 Million
Q3 2022 Nov 10, 2022	SELL	$18.11 - $22.37 $5.53 Million - $6.83 Million	-305,417 Reduced 10.22%	2,681,603 $52.7 Million
Q2 2022 Aug 12, 2022	SELL	$16.49 - $27.64 $5.78 Million - $9.68 Million	-350,375 Reduced 10.5%	2,987,020 $55.7 Million
Q1 2022 May 13, 2022	SELL	$17.15 - $28.31 $6.6 Million - $10.9 Million	-384,900 Reduced 10.34%	3,337,395 $73.3 Million
Q4 2021 Feb 14, 2022	SELL	$19.35 - $28.41 $13.6 Million - $20 Million	-704,139 Reduced 15.91%	3,722,295 $106 Million
Q3 2021 Nov 15, 2021	SELL	$16.88 - $25.23 $11.7 Million - $17.5 Million	-692,514 Reduced 13.53%	4,426,434 $93.2 Million
Q2 2021 Aug 13, 2021	BUY	$15.9 - $21.15 $81.4 Million - $108 Million	5,118,948 New	5,118,948 $96.5 Million

Others Institutions Holding CRNX

# of Institutions

236

Shares Held

90M

Call Options Held

59.7K

Put Options Held

14.8K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.37B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account